RESUMEN
BACKGROUND AIMS: Despite intensive research, to date, there is no effective treatment for neurodegenerative diseases. Among the different therapeutic approaches, recently, the use of extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) has gained attention. METHODS: In the present work, we focused on medium/large extracellular vesicles (m/lEVs) derived from hair follicle--derived (HF) MSCs, comparing their potential neuroprotective and anti-inflammatory effect against adipose tissue (AT)-MSC-derived m/lEVs. RESULTS: The obtained m/lEVs were similar in size with comparable expression of surface protein markers. The neuroprotective effect of both HF-m/lEVs and AT-m/lEVs was statistically significant in dopaminergic primary cell cultures, increasing cell viability after the incubation with 6-hidroxydopamine neurotoxin. Moreover, the administration of HF-m/lEVs and AT-m/lEVs counteracted the lipopolysaccharide-induced inflammation in primary microglial cell cultures, decreasing the levels of pro-inflammatory cytokines, tumor necrosis factor-α and interleukin-1ß. CONCLUSIONS: Taken together, HF-m/lEVs demonstrated comparable potential with that of AT-m/lEVs as multifaceted biopharmaceuticals for neurodegenerative disease treatment.
Asunto(s)
Vesículas Extracelulares , Células Madre Mesenquimatosas , Enfermedades Neurodegenerativas , Humanos , Microglía , Folículo Piloso , Antiinflamatorios/farmacología , Antiinflamatorios/metabolismo , Vesículas Extracelulares/metabolismoRESUMEN
All implanted biomaterials are targets of the host's immune system. While the host inflammatory response was once considered a detrimental force to be blunted or avoided, in recent years, it has become a powerful force to be leveraged to augment biomaterial-tissue integration and tissue repair. In this review, we will discuss the major immune cells that mediate the inflammatory response to biomaterials, with a focus on how biomaterials can be designed to modulate immune cell behavior to promote biomaterial-tissue integration. In particular, the intentional activation of monocytes and macrophages with controlled timing, and modulation of their interactions with other cell types involved in wound healing, have emerged as key strategies to improve biomaterial efficacy. To this end, careful design of biomaterial structure and controlled release of immunomodulators can be employed to manipulate macrophage phenotype for the maximization of the wound healing response with enhanced tissue integration and repair, as opposed to a typical foreign body response characterized by fibrous encapsulation and implant isolation. We discuss current challenges in the clinical translation of immunomodulatory biomaterials, such as limitations in the use of in vitro studies and animal models to model the human immune response. Finally, we describe future directions and opportunities for understanding and controlling the biomaterial-immune system interface, including the application of new imaging tools, new animal models, the discovery of new cellular targets, and novel techniques for in situ immune cell reprogramming.
Asunto(s)
Materiales Biocompatibles , Macrófagos , Animales , Materiales Biocompatibles/farmacología , Materiales Biocompatibles/uso terapéutico , Inmunidad , Prótesis e ImplantesRESUMEN
In the last few years, the importance of neoantigens in the development of personalized antitumor vaccines has increased remarkably. In order to study whether bioinformatic tools are effective in detecting neoantigens that generate an immune response, DNA samples from patients with cutaneous melanoma in different stages were obtained, resulting in a total of 6048 potential neoantigens gathered. Thereafter, the immunological responses generated by some of those neoantigens ex vivo were tested, using a vaccine designed by a new optimization approach and encapsulated in nanoparticles. Our bioinformatic analysis indicated that no differences were found between the number of neoantigens and that of non-mutated sequences detected as potential binders by IEDB tools. However, those tools were able to highlight neoantigens over non-mutated peptides in HLA-II recognition (p-value 0.03). However, neither HLA-I binding affinity (p-value 0.08) nor Class I immunogenicity values (p-value 0.96) indicated significant differences for the latter parameters. Subsequently, the new vaccine, using aggregative functions and combinatorial optimization, was designed. The six best neoantigens were selected and formulated into two nanoparticles, with which the immune response ex vivo was evaluated, demonstrating a specific activation of the immune response. This study reinforces the use of bioinformatic tools in vaccine development, as their usefulness is proven both in silico and ex vivo.
Asunto(s)
Vacunas contra el Cáncer , Melanoma , Neoplasias , Neoplasias Cutáneas , Humanos , Antígenos de Neoplasias/genética , Inmunidad , Desarrollo de Vacunas , Neoplasias/genéticaRESUMEN
AIM: To investigate the mucoadhesive strength and barrier effect of Esophacare® (Atika Pharma SL, Las Palmas de Gran Canaria) in an ex vivo model of gastro-oesophageal reflux. METHODS: An ex vivo evaluation through the Falling Liquide Film Technique with porcine esophagi was performed, compared to a positive control (Ziverel®; Norgine, Amsterdam), after different washing periods with saline, acidified saline (pH 1.2) and acidified saline with pepsin (2000U/mL). RESULTS: The adhesive mean strength on the oesophageal mucosa of Esophacare was 94.7 (6.0)%, compared to 27.6 (19.1)% of the positive control (p<0.05). These results were homogeneous across the different washes and throughout the tissue. The area covered by 1mL of Esophacare, and its respective persistence after washing was also assessed, yielding a mean global persistence of 74.29 (19.7)% vs. 18.9 (12.3)% for the control (p<0.05). In addition, after 30min exposure to acidified saline with pepsin, Esophacare shows a protective effect on the oesophageal mucosa, detectable histologically: preserved integrity and structure of the apical layers was observed, as well as reduced permeability to the washing solution. CONCLUSIONS: Esophacare shows an adhesive strength close to 100%, irrespective of the washing solution applied or the oesophageal region studied. Histologically, it reduces the abrasive effects of the acidic solution on the oesophageal epithelium, reducing permeability to the washing solution. The results in this ex vivo model of gastro-oesophageal reflux disease (GERD) support its therapeutic potential.
Asunto(s)
Esofagitis Péptica , Esofagitis , Reflujo Gastroesofágico , Humanos , Pepsina A/uso terapéutico , Esofagitis/patología , Reflujo Gastroesofágico/tratamiento farmacológico , Concentración de Iones de HidrógenoRESUMEN
There are different profiles of alcohol consumption for men and women, and different courses and prognoses associated with problems caused by alcohol abuse. There is evidence of these differences by sex, but research on their links to differences associated with gender dimensions is scarcer. In order to know what has been researched on the subject, this article reviews the literature regarding the relationship between conformity with gender norms and alcohol use and/or abuse in adults. A systematic review was conducted using the electronic databases of PubMed, PsycINFO and ScienceDirect. Twenty-four articles published in English or Spanish were included and analysed. The main findings were: 1) conformity to norms associated with traditional masculine role (dominance, womanising, aggressiveness, risk behaviours) is related to greater alcohol use; 2) conformity to norms associated with traditional feminine role (interest in home life and family care) is related with lower alcohol use. These findings provide evidence of the relationship between dimensions associated with gender and drinking. It is considered that the possibilities of modifying beliefs and gender patterns linked to risk behaviours is an aspect to be taken into account in the field of prevention, with the development of gender measures a necessary task to further deepen the study of these relationships.
El consumo de alcohol presenta perfiles diferenciales entre hombres y mujeres, existiendo diferencias igualmente respecto al curso y pronóstico de los problemas derivados del abuso de alcohol. Existe evidencia acerca de estas diferencias en función del sexo, pero la investigación acerca de su relación con diferencias en función de dimensiones asociadas al género es más escasa. Con el objetivo de conocer qué es lo que se ha investigado sobre el tema, se revisa la literatura acerca de la relación entre la conformidad con las normas de género y consumo de alcohol en adultos. Se llevó a cabo una revisión sistemática de la literatura sobre el tema en las bases de datos PubMed, PsycINFO y ScienceDirect. Se incluyeron y analizaron 24 estudios publicados en inglés o español. Los resultados más importantes fueron: 1) la conformidad con normas asociadas al rol tradicional masculino (dominancia, donjuanismo, agresividad, conductas de riesgo) está relacionada, en general, con un mayor consumo de alcohol; 2) la conformidad con normas asociadas al rol tradicional femenino (interés en vida hogareña y cuidado de la familia) se asocia con menor consumo de alcohol. Estos hallazgos proporcionan evidencia acerca de la relación entre dimensiones asociadas al género y el consumo de alcohol. Se considera que las posibilidades de modificación de las creencias y patrones de género vinculados con comportamientos de riesgo es un aspecto a considerar en el ámbito de la prevención, siendo el desarrollo de medidas de género una tarea necesaria para continuar profundizando en el estudio de estas relaciones.
Asunto(s)
Agresión , Consumo de Bebidas Alcohólicas , Asunción de Riesgos , Conducta Social , Normas Sociales , Humanos , Factores SexualesRESUMEN
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been widely associated to beneficial effect over different neurodegenerative diseases. In the present study, we tested the potential therapeutic effect of docohexanoic acid (DHA) and its hydroxylated derivate, DHAH, in a partial lesion model of Parkinson's disease (PD). One month before and four months after the striatal lesion with 6-OHDA was made, the animals were daily treated with DHA (50â¯mg/kg), DHAH (50â¯mg/kg), vehicle or saline, by intragastric administration. Animal groups under n-3 PUFA treatments exhibited a trend to improve in amphetamine-induced rotations and cylinder test. The beneficial effect seen in behavioral studies were confirmed with TH immunostaining. TH+ fibers and TH+ neurons increased in the experimental groups treated with both n-3 PUFAs, DHA and DHAH. Moreover, the n-3 PUFAs administration decreased the astrogliosis and microgliosis, in both the striatum and substantia nigra (SN), with a higher decrease of GFAP+ and Iba-1+ cells for the DHAH treated group. This experimental group also revealed a positive effect on Nrf2 pathway regulation, decreasing the positive Nrf2 immmunostaining in the striatum and SN, which revealed a potential antioxidant effect of this compound. Taking together, these data suggest a positive effect of n-3 PUFAs administration, and more concretely of DHAH, for PD treatment as it exhibited positive results on dopaminergic system, neuroinflammation and oxidative stress.
Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Neuronas Dopaminérgicas/efectos de los fármacos , Ácidos Grasos Omega-3/administración & dosificación , Neuroglía/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Parkinson/metabolismo , Anfetamina/administración & dosificación , Animales , Antioxidantes/administración & dosificación , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Dopaminérgicos/administración & dosificación , Neuronas Dopaminérgicas/metabolismo , Masculino , Actividad Motora/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Neuroglía/metabolismo , Oxidopamina/administración & dosificación , Enfermedad de Parkinson/prevención & control , Ratas Sprague-Dawley , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
BACKGROUND: Child neurodevelopment has been positively linked to maternal intake of polyunsaturated fatty acids (PUFAs) during pregnancy; however, it is unknown if that relationship persists among populations exposed to environmental neurotoxicants. OBJECTIVE: The aim of this work was to assess whether maternal dietary intake of PUFAs during pregnancy is positively associated with child neurodevelopment, whose mothers were environmentally exposed to 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT). METHODS: A prospective cohort study with 276 mother-child pairs was performed in Mexico. Neurodevelopment was assessed by Bayley Scales II from children age 1 to 30 months. Dietary PUFAs intake was estimated by Food Frequency Questionnaire at 1st and 3rd trimester of pregnancy. DDE (1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene, the main metabolite of DDT) maternal serum levels were determined by electron capture gas chromatography. Longitudinal multivariate linear mixed-effects analysis, which combines mental (MDI) and motor (PDI) Bayley scales in a single model, were performed. RESULTS: Our results show that in a sample environmentally exposed to DDT, maternal ingestion of DPA during the first trimester of pregnancy was positively associated with MDI (ß = 0.10, 95% CI 0.02, 0.18) in children from 1 to 30 months. Likewise, our results suggest that dietary ALA may be also related to MDI. CONCLUSION: DPA may benefit neurodevelopment even in populations exposed to DDT. Our results strengthen the importance of PUFAs intake during the prenatal period.
Asunto(s)
Desarrollo Infantil/efectos de los fármacos , DDT , Contaminantes Ambientales , Ácidos Grasos Insaturados/administración & dosificación , Insecticidas , Exposición Materna , Preescolar , Estudios de Cohortes , Dieta , Femenino , Humanos , Lactante , Recién Nacido , Intercambio Materno-Fetal , México , Madres , EmbarazoRESUMEN
The usefulness of nanotechnology to increase the bioavailability of drugs and decrease their toxicity may be a tool to deal with multiresistant P. aeruginosa (Mr-Pa) respiratory infections. We describe the preparation and the in vivo efficacy and safety of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) by the pulmonary and intramuscular routes. Nanoparticles showed 1-2 mg/L minimum inhibitory concentration against eight extensively drug-resistant P. aeruginosa strains. In vivo, SCM-NLC displayed significantly lower CFU/g lung than the saline and similar to that of the free SCM, even the dose in SCM-NLC group was lower than free SCM. There was no tissue damage related to the treatments. Biodistribution assessments showed a mild systemic absorption after nebulization and a notorious absorption after IM route. Altogether, it could be concluded that SCM-NLC were effective against P. aeruginosa in vivo, not toxic and distribute efficiently to the lung and liver after pulmonary or intramuscular administrations.
Asunto(s)
Colistina/análogos & derivados , Portadores de Fármacos/química , Lípidos/química , Pulmón/microbiología , Nanoestructuras/química , Pseudomonas aeruginosa/efectos de los fármacos , Animales , Colistina/administración & dosificación , Colistina/efectos adversos , Colistina/farmacología , Femenino , Inflamación/patología , Inyecciones Intramusculares , Pulmón/patología , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Nanoestructuras/toxicidad , Nanoestructuras/ultraestructura , Distribución Tisular/efectos de los fármacos , Pruebas de Toxicidad , Resultado del TratamientoRESUMEN
BACKGROUND: The use of resveratrol as a dietary supplement is limited because it is easily oxidized and, after oral ingestion, it is metabolized into enterocytes and hepatocytes. Thus, new formulations are needed in order to improve its oral bioavailability. OBJECTIVE: The objective of this study was to develop and characterize a gastro-resistant formulation of resveratrol for oral administration as a dietary supplement. METHOD: Resveratrol was encapsulated in Eudragit-coated pectin-alginate microparticles. RESULTS: The microparticle size was about 1450 µm, with an encapsulation efficiency of 41.72% ± 1.92%. The dissolution assay conducted, as specified in the European Pharmacopoeia for delayed-release dosage forms, revealed that our microparticles were gastro-resistant, because the resveratrol percentage released from microparticles in acid medium was less than 10%. In addition, the high-performance liquid chromatographic (HPLC) method developed for resveratrol content quantification in the microparticles was validated according to International Council for Harmonisation (ICH) Q2 (R1) guidelines. Finally, the biological activity of resveratrol was investigated in 3T3-L1 mature adipocytes, concluding that the encapsulation process does not affect the activity of resveratrol. CONCLUSION: In summary, the gastro-resistant microparticles developed could represent a suitable method of including resveratrol in dietary supplements and in functional foods used in obesity therapy.
Asunto(s)
Alginatos/química , Fármacos Antiobesidad/farmacología , Preparaciones de Acción Retardada , Pectinas/química , Estilbenos/farmacología , Triglicéridos/antagonistas & inhibidores , Células 3T3-L1 , Adipocitos/citología , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Animales , Fármacos Antiobesidad/metabolismo , Materiales Biomiméticos/química , Materiales Biomiméticos/farmacología , Cápsulas , Diferenciación Celular , Suplementos Dietéticos/análisis , Composición de Medicamentos/métodos , Liberación de Fármacos/efectos de los fármacos , Jugo Gástrico/química , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Humanos , Concentración de Iones de Hidrógeno , Cinética , Ratones , Tamaño de la Partícula , Ácidos Polimetacrílicos/química , Resveratrol , Estilbenos/metabolismo , Triglicéridos/biosíntesisRESUMEN
The beneficial effect of combining alginate hydrogel with graphene oxide (GO) on microencapsulated C2C12-myoblast viability has recently been described. However, the commercially available GO lacks homogeneity in size, this parameter being of high relevance for the cell fate in two-dimensional studies. In three-dimensional applications the capacity of this material for binding different kinds of proteins can result in the reduction of de novo released protein that can effectively reach the vicinity of the microcapsules. Undoubtedly, this could be an important hurdle in its clinical use when combined with alginate-PLL microcapsules. Here, we demonstrate that the homogenization of GO nanoparticles is not a mandatory preparation step in order to get the best of this material upon cell microencapsulation. In fact, when the superficial area of these particles is increased, higher amounts of the therapeutic protein erythropoietin (EPO) are adsorbed on their surface. On the other hand, we have been able to improve even more the favorable effects of this graphene derivative on microencapsulated cell viability by forming a protein biocorona. These proteins block the potential binding sites of EPO and, therefore, enhance the amount of therapeutic drug that is released. Finally, we prove that these hybrid alginate-protein-coated GO-microcapsules are functional in vivo.
Asunto(s)
Alginatos/química , Cápsulas/farmacología , Eritropoyetina/metabolismo , Grafito/farmacología , Mioblastos/efectos de los fármacos , Óxidos/farmacología , Proteínas/química , Animales , Cápsulas/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Composición de Medicamentos/métodos , Ácido Glucurónico/química , Grafito/química , Ácidos Hexurónicos/química , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Hidrogel de Polietilenoglicol-Dimetacrilato/farmacología , Ratones , Ratones Endogámicos C3H , Mioblastos/metabolismo , Nanopartículas/química , Óxidos/químicaRESUMEN
BACKGROUND: Pregnancy strongly influences the thyroid gland and its function. Thyroid guidelines recommend a 30 to 50% increase of the preconceptional levothyroxine dose in women with hypothyroidism, when pregnancy is diagnosed. CASE: A 33 year-old, 8-week pregnant woman with hypothyroidism, presents with a 2-week history of palpitations, sweating, nervousness and fatigue. Physical examination shows tachycardia (108 bpm), distal tremors and diffuse goiter. After biochemical confirmation of hyperthyroidism, her levothyroxine dose is reduced and finally interrupted. Propylthiouracil is started and maintained until after the delivery of a healthy baby at week 40. Two weeks postpartum, hyperthyroidism worsens and propylthiouracil is replaced by methimazole. Eighteen months after delivery 7.5 mCi 131Iodine was given. Two months later, hypothyroidism developed and levothyroxine was initiated. CONCLUSION: Although conversion of Hashimoto's hypothyroidism into Graves' disease is exceptional in pregnancy, pregnant women with autoimmune hypothyroidism should ideally have their TSH concentrations measured before empirically increasing their levothyroxine dose.
Asunto(s)
Enfermedad de Graves , Hipotiroidismo , Complicaciones del Embarazo , Adulto , Femenino , Enfermedad de Graves/sangre , Humanos , Hipotiroidismo/sangre , Embarazo , Complicaciones del Embarazo/sangreRESUMEN
The combination of mesenchymal stem cells (MSCs) and biomimetic matrices for cell-based therapies has led to enormous advances, including the field of cell microencapsulation technology. In the present work, we have evaluated the potential of genetically modified MSCs from mice bone marrow, D1-MSCs, immobilized in alginate microcapsules with different RGD (Arg-Gly-Asp) densities. Results demonstrated that the microcapsules represent a suitable platform for D1-MSC encapsulation since cell immobilization into alginate matrices does not affect their main characteristics. The in vitro study showed a higher activity of D1-MSCs when they are immobilized in RGD-modified alginate microcapsules, obtaining the highest therapeutic factor secretion with low and intermediate densities of the bioactive molecule. In addition, the inclusion of RGD increased the differentiation potential of immobilized cells upon specific induction. However, subcutaneous implantation did not induce differentiation of D1-MSCs toward any lineage remaining at an undifferentiated state in vivo.
Asunto(s)
Alginatos/química , Biomimética , Diferenciación Celular/efectos de los fármacos , Células Inmovilizadas/citología , Células Madre Mesenquimatosas/citología , Oligopéptidos/farmacología , Animales , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Cápsulas , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Células Inmovilizadas/efectos de los fármacos , Femenino , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Células Madre Mesenquimatosas/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , FenotipoRESUMEN
Current advances in novel drug delivery systems (DDSs) to release growth factors (GFs) represent a great opportunity to develop new therapies or enhance the effectiveness of available medical treatments. These advances are particularly relevant to the field of regenerative medicine, challenging healthcare issues such as wound healing and skin repair. To this end, biocompatible biomaterials have been extensively studied to improve in vivo integration of DDSs, to enhance the bioactivity of the released drugs and to deliver bioactive molecules in a localised and controlled manner. Thus, this review presents an overview of DDSs to release GFs for skin regeneration, particularly emphasising on (i) polymeric micro and nanospheres, (ii) lipid nanoparticles, (iii) nanofibrous structures, (iv) hydrogels and (v) scaffolds. In addition, this review summarises the current animal models available for studying wound healing and the clinical trials and marketed medications based on GF administration indicated for chronic wound treatment. FROM THE CLINICAL EDITOR: Chronic wounds currently pose a significant burden worldwide. With advances in science, novel drug delivery systems have been developed for growth factors delivery. In this comprehensive review, the authors highlighted current drug delivery systems for the enhancement of wound healing and their use in clinical settings.
Asunto(s)
Sistemas de Liberación de Medicamentos , Sustancias de Crecimiento/administración & dosificación , Regeneración , Piel/fisiopatología , Cicatrización de Heridas , Animales , HumanosRESUMEN
Sensory evaluation is the ideal tool for shelf-life determination. With the objective to develop an easy shelf-life indicator, color (L*, a*, b*, chroma and hue angle), total soluble solids (TSS), firmness (F), pH, acidity, and the sensory attributes of appearance, brightness, browning, odor, flavor, texture, color, acidity and sweetness were evaluated in fresh cut mangoes (FCM) stored at 5, 10, 15 and 20 °C. Overall acceptability was evaluated by consumers. Correlation analysis between sensory attributes and physicochemical variables was carried out. Physicochemical cut-off points based on sensory attributes and consumer acceptability was obtained by regression analysis and utilized to estimate FCM shelf-life by kinetic models fitted to each variable. The validation of the model was done by comparing the shelf life estimated by kinetic models and consumers. It was recorded large correlations between appearance, brightness, and color with L*; appearance and color with chroma and hue angle; sweetness and flavor with TSS, and between F and texture. The shelf life estimated based on consumer using a 9 point hedonic scale was in the range of 10-12, 2.3-2.6, 1.3-1.5 and 1.0-1.1 days for 5, 10, 15 and 20 °C. It was recorded large correlation coefficients between the shelf life estimated by consumer acceptability scores and physicochemical variables. Kinetic models based on physicochemical variables showed a tendency to overestimate the shelf life as compared with the models bases on the sensory attributes. It was concluded that physicochemical variables can be used as a tool to estimate the FCM shelf life.
RESUMEN
UNLABELLED: Around the world, cancer remains one of the most important causes of morbidity and mortality. Worldwide, approximately 238,000 new cases of brain and other central nervous system tumors are diagnosed every year. Nanotherapeutic approaches hold tremendous potential for diagnosis and treatment of brain cancer, including the ability to target complex molecular cargoes to the tumor sites and the capacity of crossing the blood-brain barrier and accessing to the brain after systemic administration. A new generation of "smart" nanoparticles has been designed as novel targeted delivery devices for new therapies including gene therapy, anti-angiogenic and thermotherapy. This review highlights the latest research, opportunities and challenges for developing novel nanotherapeutics for treating brain cancers. FROM THE CLINICAL EDITOR: This comprehensive review highlights the latest research results, opportunities and challenges for developing novel nanotherapeutics for treating brain cancers, with a special focus on "smart" nanoparticles as novel targeted delivery devices for new therapies including gene therapy, anti-angiogenic therapy and localized thermotherapy.
Asunto(s)
Neoplasias Encefálicas/tratamiento farmacológico , Sistemas de Liberación de Medicamentos/métodos , Antineoplásicos/administración & dosificación , Antineoplásicos/uso terapéutico , Humanos , Nanopartículas/administración & dosificación , Nanopartículas/químicaRESUMEN
Vaccination using proteins and peptides is currently gaining importance. One of the major drawbacks of this approach is the lack of an efficient immune response when the antigens are administered without adjuvants. In this study, we have taken the advantage of a combined adjuvant system in order to improve the immunogenicity of the SPf66 malarial antigen. For that purpose, we have combined poly (lactic-co-glycolic) acid microspheres, alginate, and polyinosinic polycytidilic acid. Our results show that microspheres can enhance the IgG production obtained with Freund's complete adjuvant. We have attributed this improvement to the presence of polyinosinic polycytidilic acid, since formulations comprising this adjuvant overcame the immune response from the others. In addition, our microspheres produced both IgG1 and IgG2a, leading to mixed Th1/Th2 activation, optimal for malaria vaccination. In conclusion, we have designed a preliminary formulation with a high potential for the treatment of malaria.
Asunto(s)
Alginatos , Inductores de Interferón , Ácido Láctico , Vacunas contra la Malaria , Microesferas , Poli I-C , Ácido Poliglicólico , Alginatos/química , Alginatos/farmacología , Animales , Anticuerpos Antiprotozoarios/sangre , Anticuerpos Antiprotozoarios/inmunología , Femenino , Ácido Glucurónico/química , Ácido Glucurónico/farmacología , Ácidos Hexurónicos/química , Ácidos Hexurónicos/farmacología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inductores de Interferón/química , Inductores de Interferón/farmacología , Ácido Láctico/química , Ácido Láctico/farmacología , Malaria/sangre , Malaria/inmunología , Malaria/prevención & control , Vacunas contra la Malaria/química , Vacunas contra la Malaria/farmacología , Ratones , Ratones Endogámicos BALB C , Poli I-C/química , Poli I-C/farmacología , Ácido Poliglicólico/química , Ácido Poliglicólico/farmacología , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Células TH1/inmunología , Células TH1/microbiología , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
CONTEXT: Human bone marrow mesenchymal stem cells (hBM-MSCs) show a great promise for the treatment of a variety of diseases. Despite the previous trials to encapsulate hBM-MSCs in alginate-poly-l-lysine-alginate (APA) systems, the various changes that follow immobilisation have not been ascertained yet. OBJECTIVE: Determine the various consequences derived from entrapment on cell behaviour, putting special emphasis on the ultrastructure. METHODS: hBM-MSCs were immobilised in APA microcapsules to further characterise their viability, metabolic activity, proliferation, VEGF-secretability, and morphology. RESULTS: The VEGF produced by monolayer hBM-MSCs increased significantly 1 d post-encapsulation, and was maintained for at least 4 weeks. TEM imaging of cells revealed well preserved ultrastructure indicating protein synthesis and high metabolic activity. CONCLUSION: Although APA microencapsulation did not support 100% of fully viable hBM-MSCs for long-term cultures, it was conceived to enhance both VEGF secretion and metabolic activity while not losing their stemness characteristics.
Asunto(s)
Alginatos/química , Células de la Médula Ósea/metabolismo , Células Madre Mesenquimatosas/metabolismo , Polilisina/análogos & derivados , Células de la Médula Ósea/citología , Células Cultivadas , Células Inmovilizadas/citología , Células Inmovilizadas/metabolismo , Humanos , Células Madre Mesenquimatosas/citología , Polilisina/químicaRESUMEN
The placenta praevia and acretism placental were concurrently and are conditions of abnormal placenta, in which the villus sampling invade the myometrium at the site of implantation and is associated with the partial or complete absence of the decidua. Clinical case: Patient's 32 years of age, with 34 weeks pregnancy. Obstetric history of previous cesarean section, transvaginal bleeding several times; the diagnosis by ultrasound showed placenta praevia occlusive. Surgical treatment was abdominal total hysterectomy.
Asunto(s)
Placenta Accreta , Placenta Previa , Adulto , Femenino , Humanos , Placenta Accreta/diagnóstico , Placenta Accreta/terapia , Placenta Previa/diagnóstico , Placenta Previa/terapia , EmbarazoRESUMEN
Protein therapeutics hold immense promise for treating a wide array of diseases. However, their efficacy is often compromised by rapid degradation and clearance. The synthetic smectite clay Laponite emerges as a promising candidate for their sustained delivery. Despite its unique properties allow to load and release proteins mitigating burst release and extending their effects, precise control over Laponite-protein interactions remains challenging since it depends on a complex interplay of factors whose implication is not fully understood yet. The aim of this review article is to shed light on this issue, providing a comprehensive discussion of the factors influencing protein loading and release, including the physicochemical properties of the nanoclay and proteins, pH, dispersion buffer, clay/protein concentration and Laponite degradation. Furthermore, we thoroughly revise the array of bioactive proteins that have been delivered from formulations containing the nanoclay, highlighting Laponite-polymer nanocomposite hydrogels, a promising avenue currently under extensive investigation.
RESUMEN
The use of extracellular vesicles (EVs) for drug delivery is being widely explored by scientists from several research fields. To fully exploit their therapeutic potential, multiple methods for loading EVs have been developed. Although exogenous methods have been extensively utilized, in recent years the endogenous method has gained significant attention. This approach, based on parental cell genetic engineering, is suitable for loading large therapeutic biomolecules such as proteins and nucleic acids. We review the most commonly used EV loading methods and emphasize the inherent advantages of the endogenous method over the others. We also examine the most recent advances and applications of this innovative approach to inform on the diverse therapeutic opportunities that lie ahead in the field of EV-based therapies.